OTTAWA – Health Canada has completed a safety review of hydrochlorothiazide and has found that prolonged use of the drug could increase a person’s risk for non-melanoma skin cancer.
Month: January 2019
Health Canada is warning Canadians that Ayurvedic products sold by A1 Herbal Ayurvedic Clinic Ltd. may pose serious health risks.
Postpartum psychosis is rare but very real, doctors say. And, unlike in some countries, U.S. moms who need inpatient psychiatric care can’t bring along their babies, adding to the trauma.
Health Canada is advising Canadians that Panasilver, a product distributed by Activation Products Canada Inc., in Cobourg, Ontario, is not authorized for sale and may pose serious health risks. 
At one Seattle public school, students earn their diplomas while attending daily support groups and meeting with counselors to help them stay off drugs and alcohol. There are about 40 similar schools around the country, both public and private, and more are on the drawing board.
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
Reason OTTAWA – Medical devices are vital to the health and well-being of hundreds of thousands of Canadians—many of whom could not survive without these…
While headlines continue to focus on the nation’s opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.
OTTAWA – Health Canada is informing Canadians that its safety review of Fibristal (ulipristal acetate) found a possible link between its use and the risk of a rare but serious liver injury.
California Gov. Gavin Newsom made health care a priority in his proposed state budget, asking lawmakers to authorize state-funded financial aid for health insurance, impose a penalty on uninsured Californians and expand Medicaid coverage to unauthorized immigrants.